ArticleJournal of medicinal chemistry2014

Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).

Patrick R Gentry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.